Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.
Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis.
Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort.
Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters.
MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod).
A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Multiple neurological abnormalities, including pontine hemorrhage, multiple sclerosis and aseptic meningitis, during anti-TNF-α therapy in psoriatic arthritis.
Efficacy and safety of FTY720 in patients with relapsing multiple sclerosis
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
Postural orthostatic tachycardia syndrome: additional phenotypic feature of neuromyelitis optica spectrum disorder.
Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin.
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
Ready or not: planning for health declines in couples with advanced multiple sclerosis.
Metabolite changes in radiologically isolated syndrome: More pathology than meets the eye?
Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.
A new therapeutic target for the treatment of multiple sclerosis.
Ampyra for Optic Neuritis in MS
Pages
« first
‹ previous
…
243
244
245
246
247
248
249
250
251
…
next ›
last »